Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pediatric Cholesteatoma Presenting as Persistent Otorrhea: A Case of Delayed Diagnosis Across Multiple ENT Specialists.

Clinical case reports·2026

Same author

Nursing Roles in Early Integration of Palliative and Supportive Care for Adults with Advanced Cancer: A Scoping Review.

Current oncology (Toronto, Ont.)·2026

Same author

Cancer care in conflict-affected regions: a scoping review of service delivery challenges, healthcare system adaptations, and policy implications.

Conflict and health·2026

Same author

Long-term treatment of atopic dermatitis with roflumilast cream 0.15% in patients aged 6 years or older (INTEGUMENT-OLE clinical study): a plain language summary.

The Journal of dermatological treatment·2026

Same author

Real-World Effectiveness and Safety of Deucravacitinib for Adult Patients with Plaque Psoriasis: A 16-Week Multicenter Retrospective Study of Monotherapy and Combination Therapy.

Journal of cutaneous medicine and surgery·2026

Same author

Maintenance of response with icotrokinra, a targeted oral peptide, for the treatment of moderate-to-severe plaque psoriasis: Randomized treatment withdrawal in adults from the phase 3, ICONIC-LEAD study.

Journal of the American Academy of Dermatology·2026

Search research articles

Related Experiment Video

Updated: May 10, 2025

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

Merkel-Cell Carcinoma: Local Recurrence Rate Versus Radiation Dose Study from a 949-Patient Database.

Patricia Tai¹, Michael Veness², Vimal H Prajapati³

¹Department of Oncology, University of Saskatchewan, Saskatoon, SK S7N 5A2, Canada.

Current Oncology (Toronto, Ont.)

|April 25, 2025

Summary

This summary is machine-generated.

For Merkel-cell carcinoma radiotherapy, doses below 50 Gy2 show higher local recurrence rates. Doses of 50 Gy2 or more are associated with better outcomes, suggesting an optimal radiotherapy dose is needed.

Keywords:

Merkel-cell carcinoma database local recurrence pattern of spread radiotherapy dose skin

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Related Experiment Videos

Last Updated: May 10, 2025

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Non-Destructive Evaluation of Regional Cell Density Within Tumor Aggregates Following Drug Treatment

Published on: June 21, 2022

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

Area of Science:

Oncology
Radiation Oncology

Background:

Optimal radiotherapy dosage for Merkel-cell carcinoma (MCC) is not well-established.
Limited data exists on the impact of different radiotherapy doses on local recurrence rates in MCC.

Purpose of the Study:

To evaluate the relationship between radiotherapy dose and local recurrence rates in Merkel-cell carcinoma.
To determine if specific equivalent doses in 2 Gy fractions (EQD2) influence treatment outcomes.

Main Methods:

A PubMed search identified relevant studies.
Equivalent doses in 2 Gy fractions (Gy2) were calculated and compared.
Local recurrence rates (LRR) were analyzed based on radiotherapy dose stratification.

Main Results:

Of 939 evaluable patients, 171 received radiotherapy without chemotherapy.
The overall local recurrence rate (LRR) was 23%.
Definitive radiotherapy with EQD2 < 50 Gy2 had a significantly higher LRR (23.1%) compared to ≥50 Gy2 (12.5%, p=0.0004).

Conclusions:

EQD2 < 50 Gy2 is associated with a significantly higher LRR in definitive radiotherapy for MCC.
Radiotherapy doses of ≥50 Gy2 appear more effective in preventing local recurrence.
Further prospective studies are required to establish definitive optimal radiotherapy doses for MCC.